# A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

> **NCT02161406** · PHASE2 · COMPLETED · sponsor: **Dinesh Khanna, MD, MS** · enrollment: 88 (actual)

## Conditions studied

- Diffuse Cutaneous Systemic Sclerosis

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02161406
- **Lead sponsor:** Dinesh Khanna, MD, MS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-09-12
- **Final completion:** 2018-10-17
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02161406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02161406, "A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02161406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*